Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Testing for cardiac markers at the point of care.Clin Lab Med. 2001; 21: 351-362
- Point of care testing for cardiac markers: has the time come.Point of Care. 2002; 1: 39-61
- Point of care testing for ACS in the emergency department. Emergency Medicine Cardiac Research and Education Group monograph.in: Blomkalns A. Gibler B. American College of Emergency Physicians Scientific Assembly Satellite Symposium. College of American Pathologists, Chicago IL2005 (Available at: www.emcreg.org)
- Ninety minute accelerated critical pathway for chest pain evaluation.Am J Cardiol. 2001; 88: 611-616
- The value of bedside cardiac multimarker assay in rapid and accurate diagnosis of acute coronary syndromes.Crit Pathw Cardiol. 2007; 6: 76-84
- Myocardial infarction redefined. A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.J Am Coll Cardiol. 2000; 36: 959-969
- Use of a rapid assay of subforms of creatinine kinase MB to diagnose or rule out acute myocardial infarction.N Engl J Med. 1994; 331: 561-566
- Cardiac biomarkers for rapid evaluation of chest pain.Circulation. 2001; 104: 1454-1459
- Implementation of a point of care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay.Arch Pathol Lab Med. 2003; 127: 456-460
- Ninety minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I (CHECKMATE) study.Circulation. 2001; 103: 1832-1837
- Appropriateness of point of care testing (POCT) in an emergency department.Clin Chim Acta. 2003; 333: 185-189
- Decreased patient charges following implementation of point of care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit.Clin Chim Acta. 2006; 370: 191-195
- A multicenter randomized controlled trial comparing central laboratory and point of care cardiac marker testing strategies: the disposition impacted by serial point of care markers in acute coronary syndromes (DISPO-ACS) trial.Ann Emerg Med. 2008; ([epublication ahead of print])
Storrow A. A systematic review of emergency department point-of-care cardiac markers and ED efficiency measures. Point of Care, in press.
- National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes.Clin Chem. 2007; 53: 547-551
- Cardiac marker testing as part of an emergency department point-of-care satellite laboratory in a large academic medical center. Practical issues concerning implementation.Point of Care. 2002; 1: 145-154
- Impact of ultrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction.Am J Clin Pathol. 2008; 130: 964-998
- Troponin: new tool in an old friend.CAP Today. 2009; 23: 1-17
- The search for a biomarker of ischemia.Clin Chem. 2003; 49 ([editorial]): 537-539
- Future biomarkers of ischemia and risk stratification in acute coronary syndrome.Clin Chem. 2005; 51: 810-824
- Cardiac biomarkers: a contemporary status report.Nat Clin Pract Cardiovasc Med. 2006; 3: 24-34
- Natriuretic peptides for diagnosing heart failure and beyond: what we know in 2007. Medscape continuing medical education 2007 (May).(Available at:) (Accessed May 24, 2007)
- The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.Am J Cardiol. 2005; 95: 948-954
- Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.N Engl J Med. 2004; 350: 647-654
- Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure.Clin Chem. 2007; 53: 813-822
- The impact of amino-terminal pro-brain natriuretic peptide testing on hospital length of stay and morbidity in patients with acute heart failure.Arch Pathol Lab Med. 2007; 131: 473-476
- Economics of point-of-care testing for cardiac markers and B-natriuretic peptide (BNP).Point of Care. 2005; 4: 11-14
- Medical and economic long term effects of B-type natriuretic peptide testing in patients with acute dyspnea.Clin Chem. 2007; 53: 1415-1422
- Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.J Am Coll Cardiol. 2007; 49: 1733-1739
Article info
Identification
Copyright
© 2009 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
